B
ANIK icon

Bailard’s Anika Therapeutics ANIK Stock Holding History

Bailard’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$305K Buy
+15,526
New +$297K 0.01% 620

Other funds holding ANIK

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Bailard's ANIK Position: Q3 2026 in Review

Bailard opened a new position in Anika Therapeutics (ANIK) in Q3 2026: 15,526 shares worth $305K. The stake represents 0.01% of the portfolio and ranks #620 among its holdings.

8 funds tracked by Wall St. Rank hold ANIK as of Q3 2026.

  • Bailard held 15,526 shares of Anika Therapeutics worth $305K as of Q3 2026.
  • Anika Therapeutics was a new Bailard position in Q3 2026.
  • Anika Therapeutics made up 0.01% of Bailard's portfolio in Q3 2026, its #620 holding.
  • 8 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.